nc‐RNA‐mediated high expression of CDK6 correlates with poor prognosis and immune infiltration in pancreatic cancer
Cancer Medicine · 2023-02 · 12 (4) · 5110-5123
DOI: 10.1002/cam4.5260 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2022-12. Verfasst von Yu-Xuan Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China. Hauptthemen laut MEDLINE: MicroRNAs, Pancreatic Neoplasms, RNA, Long Noncoding. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Background
Emerging evidence manifests that cyclin‐dependent kinase 6 (CDK6) plays an essential part in the initiation and progression of several types of human cancer, and its descending expression is correlated with an adverse prognosis. However, the precise role of CDK6 in Pancreatic cancer (PC) remains obscure.
Aims
To identify the potential ceRNA regulatory axis of CDK6 in PC and explore its relationship with immune cells and immune checkpoints. Materials & Methods Using The Cancer Genome Atlas TCGA and GTEx data analyze the expression and survival of CDK6 in patients in pan‐cancer, and cellular experiments were performed to verify the effect of CDK6 on cell function. Using GEPIA and STARBASE databases to analyze prognosis, expression and survival, and identify non coding RNA (ncRNA) that mediates CDK6 overexpression. The TIMER 2.0 database was used for immune correlation analysis.
Results
We revealed CDK6 might be an oncogene in PC, and the HOXA11‐AS /NR2F1‐AS1‐ miR‐454‐3p axis was identified as the possible upstream ncRNA‐associated pathway of CDK6 in PC. In addition, CDK6 show significant association with three immune checkpoints (PD‐L1, PD‐L2, and HAVCR2), the infiltration level of immune cells, and immunity biomarkers.
Discussion
We discussed some applications of CDK6 in breast cancer, melanoma, and hemorrhagic malignancies. The role of miR‐15a‐5p, HOXA11‐AS and NR2F1‐AS1 in tumor development was also discussed based on existing studies. The potential mechanism of CDK6 affecting immune cells in pancreatic cancer was discussed.
Conclusions
Overall, these results established that nc‐RNA‐mediated high expression of CDK6 is associated with patient outcomes and immune invasion in pancreatic cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
- Department of Hepatobiliary Surgery, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
- Department of Pancreatic Surgery, General Surgery, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
ORCID-Profile: De-Xin Yu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
Zitieren
APA
Zhao, Y. X., Xu, B. W., Wang, F. Q., Jiang, F. Y., Xu, J. W., & Yu, D. X. (2023). nc‐RNA‐mediated high expression of CDK6 correlates with poor prognosis and immune infiltration in pancreatic cancer. Cancer Medicine, 12(4), 5110-5123. https://doi.org/10.1002/cam4.5260
Vancouver
Zhao YX, Xu BW, Wang FQ, Jiang FY, Xu JW, Yu DX. nc‐RNA‐mediated high expression of CDK6 correlates with poor prognosis and immune infiltration in pancreatic cancer. Cancer Medicine. 2023;12(4):5110-5123. doi:10.1002/cam4.5260
BibTeX
@article{Zhao2023,
author = {Zhao, Yu-Xuan and Xu, Bo-Wen and Wang, Fang-Qing and Jiang, Feng-Yang and Xu, Jian-Wei and Yu, De-Xin},
title = {nc‐RNA‐mediated high expression of CDK6 correlates with poor prognosis and immune infiltration in pancreatic cancer},
journal = {Cancer Medicine},
year = {2023},
volume = {12},
number = {4},
pages = {5110--5123},
doi = {10.1002/cam4.5260}
}
EUVIMED